Novartis plans to seek approval for CAR-T in slow-growing lymphoma after Phase II success August 5, 2020 Auto Bot Basel, BioPharma, biopharma nl, CAR-T, cell therapy, Follicular Lymphoma, Kymriah, Novartis, Oncology, Switzerland 0 The company said the study of Kymriah in follicular lymphoma met its primary endpoint, though it did not disclose the trial data. It plans to submit approval applications to the FDA and EMA next year.